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Summary We report DNA interstrand cross-linking caused by the anti-tumour indoloquinone E09 following
reductive activation with purified rat liver DT-diaphorase or xanthine oxidase. Reduction was a necessary
event for cross-linking to occur. DNA cross-link formation by E09 following DT-diaphorase reduction was
completely inhibited by adding 1O 1M dicoumarol, whereas only a minor effect of dicoumarol on xanthine
oxidase-mediated DNA cross-linking by E09 was observed. DNA cross-linking was pH dependent, with
increasing cross-link formation from pH 5.5 to 7.0 for both DT-diaphorase and xanthine oxidase mediated
reactions. Also, conversion of E09 upon reduction was pH dependent. However, in contrast to DNA
cross-linking, conversion rates of E09 decreased at higher pH. E09 was shown to be more efficient in DNA
cross-linking than mitomycin C under identical conditions, using both DT-diaphorase and xanthine oxidase
reductive activation at pH 5.5 and 7.0. This study indicates that the anti-tumour activity of E09 may be at
least partly mediated by interstrand DNA cross-link formation, and that various reducing enzymes may be
important for activation of E09 in vitro and in vivo.
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The indoloquinone E09 (see Figure 1) is one of a large
group of synthetic quinones based on the clinically used
anti-tumour drug mitomycin C (Oostveen and Speckamp,
1987). Because of its activity in solid tumours and lack of
bone marrow toxicity it is presently undergoing clinical trials
(Hendriks et al., 1993). Like mitomycin C, E09 is expected
to be activated bioreductively. Three active centres, i.e. the
vinylic group at C-2, the hydroxymethyl group at C-3 and
the aziridinyl group at C-5, are possibly activated upon
reduction of the quinone group of E09 (Oostveen and Spec-
kamp, 1987). Reduction of E09 can be performed very
efficiently with the two-electron reducing enzyme DT-
diaphorase [NAD(P)H (quinone acceptor) oxidoreductase,
EC 1.6.99.2] (Bailey et al., 1992a). The importance of this
enzyme for the anti-tumour activity of E09 is indicated by
the correlation that was found between the amount of DT-
diaphorase present in a tumour cell and the anti-tumour
activity of E09 (Robertson et al., 1992). However, other
reducing enzymes may be able to activate E09 as well.
Bioreductive alkylation of DNA has been suggested as the
molecular basis of the anti-tumour effect of E09 (Walton et
al., 1991, 1992). Upon reductive activation of E09 by
purified DT-diaphorase DNA single-strand breaks were
reported. This DNA strand break formation was unaffected
by superoxide dismutase, and therefore an alkylating species
could be involved in this process (Walton et al., 1991).
Moreover, with use of alkaline elution techniques, the
presence of DNA cross-links in rat Walker tumour cells was
demonstrated, and the involvement of DT-diaphorase was
suggested (Bailey et al., 1992b). However, DNA cross-linking
by E09 upon reduction has never been demonstrated directly
in a cell-free system.
In this paper we report the conversion of E09 upon
reduction, using the two-electron reducing enzyme DT-dia-
phorase as well as xanthine oxidase. Xanthine oxidase, which
is normally involved in the oxidation of hypoxanthine to
xanthine and further oxidation of xanthine to uric acid, has
been reported to be capable of reducing various quinone
compounds. In this case, xanthine or NADH can be used as
electron donors (Pan et al., 1984; Lusthof et al., 1990). In
case NADH is used as co-factor xanthine oxidase mainly
functions as a one-electron reducing enzyme (Nakamura and
Yamazaki, 1973). Furthermore, we investigated whether
activation of E09 with DT-diaphorase or xanthine oxidase
could result in DNA interstrand cross-linking, using an
ethidium bromide fluorescence assay.
Materials and methods
E09 was kindly provided by the EORTC New Drug Devel-
opment Office, Amsterdam, The Netherlands. Mitomycin C
was from Bristol-Myers. Calf thymus DNA and bovine
serum albumin (BSA) were obtained from Boehringer Mann-
heim (Almere, The Netherlands). Xanthine oxidase (grade
III), NADH and NADPH were purchased from Sigma (St
Louis, MO, USA). Methanol (HPLC quality) was from
Westburg (Leusden, The Netherlands). Acetonitrile (HPLC
quality) was obtained from Rathburn (Walkerburn, UK).
N,N-Dimethylformamide (DMF) was from Baker (Deventer,
The Netherlands). 10 mM stock solutions of E09 and
mitomycin C in DMF were used. These stock solutions were
stored in the dark at 4°C.
Purification ofrat liver DT-diaphorase
DT-diaphorase was purified from livers from uninduced male
Wistar rats (250 g), using Cibacron blue affinity chromato-
graphy, essentially as described by Sharkis and Swenson
(1989). DT-diaphorase activity was determined at 25°C using
DCPIP as electron acceptor. The system contained 0.15 mg
ml1- BSA, 200jLM NAD(P)H and 40 ItM 2,6-dichlorophenol-
indophenol (DCPIP) in 50 mM Tris-HCI, pH 7.5. Activity
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Figure 1 Structure of E09.
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was measured as the dicoumarol-inhibitable conversion of
DCPIP, as measured by the absorbance change at 600 nm. In
the presence of 50ZlM dicoumarol, conversion of DCPIP was
inhibited by more than 95%. One unit (U) of DT-diaphorase
is defined as the amount converting 1 gmol of DCPIPmin'
under the conditions mentioned above.
Conversion ofE09 by DT-diaphorase andxanthine oxidase
The reactions were performed under nitrogen at 25°C. Reac-
tion mixtures contained 100tM EO9, 0.15 mgml'l BSA and
75mUml-' DT-diaphorase or 125mUml-1 xanthine oxi-
dase in 0.1 M phosphate buffer, pH 7.5, 6.5 or 5.5. One unit
of xanthine oxidase is defined as the amount converting
1 gLmol xanthinemin-' in 0.1 M phosphate buffer, pH 7.4, at
25°C. The reaction mixture was purged for 10 min with
nitrogen to remove air before the reaction was started by
adding NADH or NADPH (final concentration 500gsM, total
volume 1.0 ml). Samples were taken at several time intervals,
and were mixed immediately with an equal amount of aceto-
nitrile. After centrifuging for 1 min at 16 000 r.p.m., the con-
version of E09 was monitored by high-performance liquid
chromatography (HPLC), using a 4.6 x 200 mm Spherisorb
S5-ODS2 Cl8 column with UV detection at 280 nm. EO9 and
metabolites were eluted with 49.5:49.5:1 (v/v) methanol-
water-0.5 M phosphate buffer, pH 7.4, at a flow rate of
0.5 ml min-'.
DNA cross-linkformation by E09
DNA cross-linking by EO9 at 25°C was assayed at pH 5.5
and 7.0. A solution of 100gM EO9, 350fg ml-I calf thymus
DNA, 0.15 mgml lBSA, and 75 mU ml1 DT-diaphorase
or 125 mU ml1 xanthine oxidase was purged with nitrogen
for 10 min. Subsequently the reduction was started by adding
NADH or NADPH to a final concentration of 500ItM (total
volume 1.0 ml). After 30 min the reaction was stopped and
the samples were treated as described elsewhere (Maliepaard
et al., 1993). Essentially, the assay makes use of the different
fluorescence yields of ethidium bromide intercalated in
double-standed DNA or attached to single-stranded DNA.
The ethidum bromide fluorescence yields before denaturation
and 10 min after denaturation of the DNA in the samples
were used to calculate a relative measure of the amount of
DNA interstrand cross-links formed.
Results
Conversion ofE09 upon reduction
Conversion of EO9 was followed with HPLC analysis.
Incubation of EO9 at pH 7.5 and pH 6.5, without enzyme or
co-factor, did not result in any HPLC-detectable conversion
of EO9 within 1 h. However, EO9 appeared to be unstable at
pH 5.5, with a half-life of approximately 60 and 150 min in
0.1 M phosphate buffer and 0.15 M Tris-acetate buffer respec-
tively. This instability of EO9 at pH 5.5 has also been
reported by others (Phillips et al., 1992). At this pH, one
metabolite was formed (see Figures 2a and b), which was
attributed to the aziridine ring opened product EOSA, the
main acid hydrolysis product of E09 (Phillips et al., 1992).
Because increased cytotoxicity of EO9 at lower pH has
been reported (Phillips et al., 1992), conversion of E09 fol-
lowing reduction was measured at various pH values. At all
pH values used, reduction of EO9 by DT-diaphorase as well
as by xanthine oxidase resulted in conversion of EO9. Chro-
matograms demonstrating the conversion of E09 upon DT-
diaphorase reduction at pH 7.5 and pH 5.5 are shown in
Figures 2c and d respectively. Xanthine oxidase-mediated
reduction of EO9 yielded identical metabolite patterns, as did
reactions that were performed in 0.15 M Tris-acetate buffer
(data not shown). EO9 conversion rates in phosphate buffer
are shown in Table I. The conversion rates at pH 5.5 are
corrected for the acid-catalysed spontaneous conversion of
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Figure 2 HPLC analysis of E09. (a) E09 in 0.1 M phosphate
buffer, pH 7.5. (b) E09 after 2.5 h in 0.1 M phosphate buffer,
pH 5.5, at 25°C. (c) E09 after 40min of reduction with 75 mU
ml-I DT-diaphorase, 500gM NADH and 0.15mgml-' BSA in
0.1 M phosphate buffer pH 7.5. (d) E09 after 20 min of reduction
with 75mUml-' DT-diaphorase, 500 LM NADH and 0.15mg
ml- BSA in 0.1 M phosphate buffer pH 5.5.
E09. Conversion of E09 upon DT-diaphorase-mediated
reduction was accelerated at lower pH. However, for xan-
thine oxidase-mediated reduction of E09, after an initial
increase in conversion rate observed upon lowering the pH
from 7.5 to 6.5, a decrease was noted upon further lowering
the pH to 5.5.
DT-diaphorase-mediated conversion of E09 was inhibited
completely by omitting NAD(P)H, or by adding 10liM ofthe
frequently used DT-diaphorase inhibitor dicoumarol (Table
I). E09 conversion by xanthine oxidase was inhibited by
omitting NADH. However, adding 10liM dicoumarol to this
reaction mixture resulted in an increased conversion rate of
E09 (Table I). This potentiation of xanthine oxidase-
mediated metabolism by dicoumarol has also been reported
for mitomycin C (Gustafson and Pritsos, 1992).
Interestingly, upon reduction of E09 at pH 7.5, only small
amounts of the aziridinyl ring-opened product EOSA are
observed (see Figure 2c). Moreover, the observed amount of
EO5A, formed at pH 5.5 (see Figure 2d), can be completely
accounted for by non-enzymatic ring opening. Once formed,DNAintstand crosslinking caused by E09
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TableI Conversionrates(nmol min- )of100 lM EO9uponreduction
with 75 mU ml ' DT-diaphorase or 125 mUml-' xanthine oxidaseand
500JLM NADH in 0.1 M phosphate buffer at indicated pH under
hypoxic conditions. Values are means±s.d. from at least three
experiments, and are corrected for non-enzymatic degradation ofE09
at pH 5.5 (initial spontaneous degradation rate at this pH:
0.5±0.1 nmolmin-')
Conversion ofE09 (nmolmin-')
DT-diaphorase Xanthine oxidase
pH 5.5 4.2±1.5 0.6±0.2
pH 6.5 2.6±0.5 1.1±0.1
pH 7.5 1.5±0.1 0.46±0.01
pH 7.5+IO1M DICa NDb 1.7±0.1
DIC, dicoumarol. bND, no detectable conversion in 1 h.
Table H Per cent DNA interstrand cross-link formation under
hypoxic conditions by 1OO1M E09 upon reductive activation using
75 mU ml-' DT-diaphorase or 125 mU ml-' xanthine oxidase and
500tiM NADH in 0.15 M Tris-acetate buffer, pH 5.5 and pH 7.0, in the
presence of calf thymus DNA (350figml-'). Values are means±s.d.
from at least four experiments
Per cent DNA interstrand cross-link
formation
Compound DT-diaphorase Xanthine oxidase
E09 pH 5.5 24.1±1.2 3.7±0.3
pH 7.0 50.2±1.3 12.3±1.0
pH 7.0+1IOIM DICa 2.5±1.0 9.4±0.4
EO5A pH 7.0 0.5±0.3 NMb
MMC pH 5.5 8.0±3.7 2.8±0.4
pH 7.0 2.9±2.5 3.5±1.5
-DIC, dicoumarol. bNM, not measured.
E05A is relatively stable under the reductive conditions em-
ployed in these experiments (data not shown). This suggests
that upon reduction of E09 aziridinyl ring opening does not
occur under the conditions as described in this paper. How-
ever, concerted reactions, involving both aziridinyl ring open-
ing and reactions at the vinyl or hydroxymethyl groups of
E09, cannot be excluded. Three metabolites other than
EOSA are observed in the chromatograms upon reduction of
E09 (denoted I, II and III in Figure 2). These metabolites
were not further characterised.
DNA interstrand cross-linkformation
Before denaturation, the absolute fluorescence yields of con-
trol DNA samples and E09-treated DNA samples were
essentially equal. Only after denaturation (and 10 min
renaturation) did differences in fluorescence yields between
control samples and E09-treated samples become apparent.
Therefore, it is clear that reduction of E09 by DT-dia-
phorase or xanthine oxidase in the presence of calf thymus
DNA results in interstrand cross-link formation (Table II),
whereas loss of DNA owing to E09-induced DNA strand
breaks was not observed. For DT-diaphorase as well as for
xanthine oxidase-mediated DNA cross-linking by E09, a
distinct pH dependency was noticed, with a higher amount of
DNA interstrand cross-links formed at higher pH. Using the
co-factor NADPH instead of NADH in DT-diaphorase
mediated reactions resulted in an equal amount of DNA
cross-links formed by E09. No DNA cross-linking by E09
was detected without NADH or NADPH or without enzyme
(data not shown). Furthermore, DT-diaphorase-mediated
DNA cross-linking by E09 was prevented by adding 1O AM
dicoumarol. However, xanthine oxidase-mediated DNA
cross-linking was inhibited only for approximately 24% in
the presence of dicoumarol (Table II). The acid hydrolysis
product EOSA appeared to be a very poor cross-linking
agent under the conditions as described in this paper (Table
II).
DNA cross-linking by E09 was compared with that by
mitomycin C. Mitomycin C is known to inhibit DT-diaphor-
ase at pH 7.0 owing to covalent binding to the enzyme (Ross
et al., 1993). The relatively small number of DNA cross-links
detected at pH 7.0 using DT-diaphorase reduction of mito-
mycin C (Table II) can be explained by this enzyme inhibi-
tion. At pH 5.5, increased DNA cross-linking by mitomycin
C was observed. This increased DNA cross-link formation by
mitomycin C following DT-diaphorase reduction at lower pH
was also noted by others (Siegel et al., 1992; Ross et al.,
1993). However, following DT-diaphorase reductive activa-
tion at pH 5.5, E09 is clearly a more potent DNA cross-
linker than mitomycin C (Table II). Notably, also, xanthine
oxidase-mediated reductive activation of E09 yielded more
DNA interstrand cross-links than mitomycin C under iden-
tical conditions (Table II). However, this difference in DNA
cross-linking efficiency was less pronounced than noted fol-
lowing DT-diaphorase reduction.
Discussion
Both reduction with the obligate two-electron reducing
enzyme DT-diaphorase and the mainly one-electron reducing
enzyme xanthine oxidase results in conversion of E09 and its
activation to a DNA cross-linking agent. Comparing DNA
cross-linking data with conversion data, the pH dependence
of conversion of E09 and DNA cross-linking by it appears
to be reversed: lowering pH results in accelerated conversion,
but less DNA cross-linking by E09. This holds for both the
DT-diaphorase and xanthine oxidase-mediated reactions.
Differences between buffers used in conversion and DNA
cross-linking experiments do not appear to be crucial, as the
metabolite patterns upon reduction and pH dependency of
the conversion in 0.15 M Tris-acetate buffer were similar to
those obtained in 0.1 M phosphate buffer. Furthermore, the
smaller number of cross-links formed at lower pH can only
partly be explained by acid hydrolysis of E09, and resulting
formnation of the less active EO5A, at this low pH. From the
above-mentioned half-life of E09 in 0.15 M Tris-acetate
buffer at pH 5.5, it is concluded that in the DNA cross-
linking experiment at this pH more than 60% of E09 is still
present (or already reduced) after 40 min of incubation. A
reversed effect of pH on E09 conversion and DNA cross-
linking was also evident in experiments using dicoumarol in
xanthine oxidase-mediated reactions: by adding 10 JLM
dicoumarol, conversion of E09 in the absence of DNA was
enhanced by a factor 3.5 (Table I), whereas DNA cross-
linking by E09 diminished by 24% (Table II). Although the
exact mechanism of action of E09 is presently unknown,
reasons for the deviating pH dependence of conversion and
DNA cross-linking can be hypothesised. Firstly, the chemical
mechanism responsible for the formation of E09 metabolites
may be different in the absence or in the presence of
nucleophiles (e.g. DNA). If so, such behaviour can result in
different pH profiles for electrophilic and nucleophilic reac-
tions. Such a phenomenon has been described for mitomycin
C (Schiltz and Kohn, 1992). Another explanation for the
lower amount of DNA cross-links formed at pH 5.5 may be
a decreased lifetime of the alkylating intermediates of E09 at
lower pH, which would diminish DNA adduct formation.
More research is needed to clarify this matter.
Cytotoxicity of E09 has been shown to increase at lower
extracellular pH in a human adenocarcinoma DLD-1 and
breast carcinoma MCF-7 cell line (Phillips et al., 1992). In
contrast to this, our results show diminished DNA cross-link
formation at lower pH. Although sensitivity of cells towards
DNA cross-linking damage may increase at lower extracel-
lular pH, this could suggest that other mechanisms of action
also play a role in the cytotoxicity of E09. A candidate
mechanism is induction of single-strand DNA breaks, which
have been demonstrated in pBR 322 plasmid DNA following
DT-diaphorase reduction of E09 (Walton et al., 1991). The
effect of lower pH on induction of DNA single-strand breaks
by E09 is not clear at this moment. Notably, DNA inter-
strand cross-linking is regarded as an important mechanism
for anti-tumour activity of bioreductive quinones (Workman,DNAintertandcrosslinking caused by E09
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1992). Therefore, it is interesting that under our conditions
E09 is a more potent DNA cross-linking agent than mito-
mycin C, using DT-diaphorase as well as xanthine oxidase
reductive activation. DNA cross-linking by E09 can there-
fore be regarded as potentially important for anti-tumour
activity of this compound.
DNA cross-linking by E09 upon reduction by DT-dia-
phorase is interesting in view of the correlation between
DT-diaphorase content and the activity of E09 in tumour
cells (Robertson et al., 1992; Walton et al., 1992). This
supports the conclusions of these authors that DT-dia-
phorase reduction may be important for the anti-tumour
effect ofE09 in vitro and in vivo. Moreover, in some tumours
the content of DT-diaphorase is increased several fold, com-
pared with non-malignant cells (Cresteil and Jaiswal, 1991).
However, our results with xanthine oxidase indicate that
other reducing enzymes, the amount of which can also be
elevated in certain tumour cells (Nemeikaite and Cenas,
1993), may potentially be activators of E09 to a DNA
alkylating species as well. Therefore these enzymes should not
be excluded in studying the activation mechanisms of E09.
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